{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "CELLECTIS SP.ADR 1 EO-,05", "longName": "Cellectis S.A.", "messageBoardId": "finmb_1216695", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -4.790415, "regularMarketPrice": 1.59, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1428904800000, "priceHint": 4, "epsTrailingTwelveMonths": -1.77, "epsForward": -2.83, "epsCurrentYear": -2.39, "priceEpsCurrentYear": -0.66527194, "sharesOutstanding": 55583800, "bookValue": 2.583, "fiftyDayAverage": 1.766, "fiftyDayAverageChange": -0.176, "fiftyDayAverageChangePercent": -0.09966025, "twoHundredDayAverage": 2.3306, "twoHundredDayAverageChange": -0.7406, "twoHundredDayAverageChangePercent": -0.31777224, "marketCap": 98596856, "forwardPE": -0.5618375, "priceToBook": 0.61556333, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.8 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.07999992, "regularMarketTime": 1683871252, "regularMarketDayHigh": 1.59, "regularMarketDayRange": "1.59 - 1.59", "regularMarketDayLow": 1.59, "regularMarketVolume": 150, "regularMarketPreviousClose": 1.67, "bid": 1.59, "ask": 1.74, "bidSize": 200, "askSize": 200, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.59, "averageDailyVolume3Month": 3, "averageDailyVolume10Day": 15, "fiftyTwoWeekLowChange": 0.00999999, "fiftyTwoWeekLowChangePercent": 0.0063291076, "fiftyTwoWeekRange": "1.58 - 3.82", "fiftyTwoWeekHighChange": -2.23, "fiftyTwoWeekHighChangePercent": -0.5837696, "fiftyTwoWeekLow": 1.58, "fiftyTwoWeekHigh": 3.82, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "ZVAA.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "8, rue de la Croix Jarry", "city": "Paris", "zip": "75013", "country": "France", "phone": "33 1 81 69 16 00", "fax": "33 1 81 69 16 06", "website": "https://www.cellectis.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A to treat relapsed or refractory for non-hodgkin lymphoma (NHL); and ALLO-715 for the treatment of multiple myeloma. It also develops UCART22 to treat B-cell acute lymphoblastic leukemia; UCARTCS1 and ALLO-605 for the treatment of multiple myeloma; ALLO-316 for renal cell carcinoma; UCART123 for the treatment of acute myeloid leukemia; and UCART 20x22 for relapsed or refractory B-Cell NHL. The company has strategic alliances with Allogene Therapeutics, Inc. and Les Laboratoires Servier; research collaboration and exclusive license agreement with Iovance Biotherapeutics; and collaboration and license agreement with Cytovia Therapeutics. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.", "fullTimeEmployees": 231, "companyOfficers": [{"maxAge": 1, "name": "Dr. Andre  Choulika Ph.D.", "age": 57, "title": "Co-Founder, CEO & Director", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 744016, "fmt": "744.02k", "longFmt": "744,016"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David J. D. Sourdive Ph.D.", "age": 55, "title": "Deputy CEO, Exec. VP of CMC & Manufacturing and Directorr", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 528920, "fmt": "528.92k", "longFmt": "528,920"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Bing C. Wang M.B.A., Ph.D.", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Valerie  Cros", "title": "Principal Financial Officer & Principal Accounting Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jean Charles Epinat", "title": "Chief Technological Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Philippe  Duchateau Ph.D.", "age": 59, "title": "Chief Scientific Officer", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephan  Reynier M.Sc., MSc", "age": 53, "title": "Chief Regulatory & Pharmaceutical Compliance Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marie-Bleuenn  Terrier", "age": 40, "title": "Gen. Counsel & Sec. of the Board of Directors", "yearBorn": 1982, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Pascalyne  Wilson", "title": "Director of Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kyung  Nam-Wortman", "age": 52, "title": "Exec. VP & Chief HR Officer", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 10, "boardRisk": 10, "compensationRisk": 6, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}